Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Ocwen Financial Corporation ( OCN - Analyst Report ) reported third quarter 2011 earnings of 19 cents per share, missing the Zacks Consensus Estimate by 2 cents. However, this compares favorably with the prior-year quarter's loss of 9 cents.
Ocwen’s net income for the reported quarter stood at $20.2 million as against a net loss of $8.8 million in the year-ago quarter.
During the quarter under review, Ocwen announced the completion of its acquisition of Litton Loan Servicing, a unit of Goldman Sachs Group Inc. ( GS - Analyst Report ) , for $263.7 million. The company had announced the acquisition in the second quarter.
Further, on October 19, Ocwen announced a deal to acquire Saxon Mortgage Services Inc., a mortgage subsidiary of Morgan Stanley ( MS - Analyst Report ) . The company would pay the base purchase price of $59.3 million, in addition to an estimated $1.4 billion for servicing advance receivables outstanding. The transaction is anticipated to close in the first quarter of 2012.
The year-over-year improvement in Ocwen’s results was mainly driven by higher total revenue and decline in operating expenses. However, these positives were partially offset by higher interest expenses as well as lower interest income.
Quarter in Detail
Ocwen’s total revenue surged 28.1% year over year to $122.5 million. The improvement in total revenue was mainly attributable to a 30.3% rise in servicing and sub-servicing fees and a 16.5% increase in process management fees, which were partly offset by a 48.5% drop in other revenues.
Operating expenses fell 29.7% year over year to $65.7 million in the reported quarter. The decline was mainly due to lower compensation and benefits costs, as well as professional services expenses. However, these were partly mitigated by a rise in expenses related to amortization of mortgage servicing rights, servicing and origination costs, along with occupancy and equipment costs.
Interest income declined 26.8% year over year to $2.19 million, while interest expenses leaped 14.4% year over year to $27.7 million.
Balance Sheet and Other Updates
As of September 30, 2011, Ocwen recorded cash of $152.03 million compared with $127.8 million as of December 31, 2010. Debt securities totaled $82.6 million as of September 30, 2011, in line with the figures as of December 31, 2010.
During the reported quarter, Ocwen closed a $575 million Senior Secured Term loan (SSTL) to fund the Litton acquisition and made the first quarterly amortization payment of $14.4 million on September 30, 2011.
During the third quarter, Ocwen completed 15,743 modifications (including 16% in Home Affordable Modification Program), which was within the company’s guidance of 13,000−16,000 modifications.
Our Viewpoint
Although the near-term outlook remains cautious owing to market volatility and subprime MSR market contraction, Ocwen remains committed to new business acquisitions and loan modifications. These will likely convert into increased profitability over time. Additionally, the company’s acquisition of Litton and Saxon would benefit its financials over the long term.
Furthermore, with the ongoing home price deterioration, Ocwen might get even more opportunities to acquire distressed servicing portfolios at low prices.
Ocwen currently retains a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating. Also, considering the fundamentals, we are maintaining our long-term “Neutral” recommendation on the stock.
Read the full reports :
Analyst Report on MS
Analyst Report on OCN
Analyst Report on GS